Companies: 10,795·Total market cap: $144.5T
GreenLight Biosciences Holdings

GreenLight Biosciences Holdings

GRNANASDAQHealthcare
$0.30
$-0.00(-0.03%)
Market Cap$45428456
P/E Ratio—
52W High$5.9
52W Low$0.177
SEC Filings

GreenLight Biosciences Holdings (GRNA) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001822691 · GRNA · NASDAQ · as of Jun 9, 2026

Filing snapshot

344
Total Filings
15-12G
Latest Form
2023-08-11
Most Recent
2022
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001822691 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2023-03-28
Fiscal Year End
Mar 28, 2023
Accession No.
0000950170-23-010351
Primary Document
grna-20221231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001822691 · Accession 0000950170-23-010351

Latest Key Filings

10-QQuarterly Report
10-Q
2023-05-11
View 10-Q on SEC
8-KCurrent Report
8-K/A
2023-07-28Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
15-12G15-12G
15-12G
2023-08-11
View
SC 13D/ASC 13D/A
SC 13D/A
2023-07-28
View
SC 13D/ASC 13D/A
AMENDMENT TO SCHEDULE 13D
2023-07-28
View
8-K/ACurrent Report (Amended)
8-K/A
2023-07-28
View
SC 13D/ASC 13D/A
SC 13D/A
2023-07-27
View
3Initial Statement of Beneficial Ownership
3
2023-07-27
View
SC 13D/ASC 13D/A
SC 13D/A
2023-07-27
View
3Initial Statement of Beneficial Ownership
3
2023-07-26
View
SC 13D/ASC 13D/A
SC 13D/A
2023-07-26
View
SC 13D/ASC 13D/A
SC 13D/A
2023-07-26
View
SC 13D/ASC 13D/A
SCHEDULE 13D/A
2023-07-26
View
SC 13D/ASC 13D/A
AMENDMENT NO. 1 TO SCHEDULE 13D
2023-07-26
View
SC 13D/ASC 13D/A
SC 13D/A
2023-07-26
View
EFFECTEFFECT
EFFECT
2023-07-25
View
EFFECTEFFECT
EFFECT
2023-07-25
View
Showing 1–15 of 268 filingsForm 4 / 144 hidden· 344 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001822691  |  Exchange: NASDAQ · Healthcare

GreenLight Biosciences Holdings (NASDAQ: GRNA) has submitted 344 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2022. As a Healthcare sector company with CIK 0001822691, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is GreenLight Biosciences Holdings's most comprehensive regulatory disclosure. The most recent GreenLight Biosciences Holdings 10-K was filed on 2023-03-28 for fiscal year ending 2023. Historical GRNA 10-K annual reports are available from 2020 through 2023.

Investors researching GreenLight Biosciences Holdings SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
SYRE SEC Filings →ALVR SEC Filings →BLUE SEC Filings →ERYP SEC Filings →MGTA SEC Filings →PSTI SEC Filings →STSA SEC Filings →RENB SEC Filings →
→ GRNA Financials→ GRNA Earnings→ GRNA Insider Trades

Frequently Asked Questions

GRNA SEC Filings · 8 questions

GreenLight Biosciences Holdings (GRNA) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 344 filings and access original documents at no cost. GreenLight Biosciences Holdings's CIK is 0001822691.

GRNA SEC filingsGreenLight Biosciences Holdings SEC documentsfind GRNA 10-K